Clinical trial
Effects of Benfotiamine on Intraepidermal Nerve Fiber Density (IENFD)and Diabetic Neuropathy in Subjects With Sensorimotor Diabetic Polyneuropathy: a Double-blind, Randomized, Placebo-controlled Parallel Group Pilot Study Over 12 Months.
NCT01868191 is registered in ClinicalTrials.gov with Diabetes Schwerpunktpraxis as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Benfotiamine on Intraepidermal Nerve Fiber Density (IENFD)and Diabetic Neuropathy in Subjects With Sensorimotor Diabetic Polyneuropathy: a Double-blind, Randomized, Placebo-controlled Parallel Group Pilot Study Over 12 Months.
- Lead sponsor
- Diabetes Schwerpunktpraxis
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- July 31, 2013
- Completion date
- December 31, 2014
- Enrollment
- 22 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.